Skip to content

Diagnosis and Pathology: Understanding Your Skin Biopsy and Blood Tests

Last updated:

The gold standard for diagnosing Dermatitis Herpetiformis (DH) is a Direct Immunofluorescence (DIF) skin biopsy taken from normal-looking skin next to a blister. A positive result will show granular IgA deposits. Blood tests for tTG and TG3 antibodies support the diagnosis but may be negative.

Key Takeaways

  • A Direct Immunofluorescence (DIF) skin biopsy is the most critical test for confirming Dermatitis Herpetiformis.
  • The biopsy must be taken from normal-looking skin next to a blister and processed as fresh frozen tissue, not in formalin.
  • Granular IgA deposits in the papillary dermis are the hallmark diagnostic finding on a DH pathology report.
  • Blood tests for IgA anti-tTG and anti-eTG (TG3) support the diagnosis, but can be negative in some confirmed DH patients.
  • Total IgA levels should be checked to rule out a natural deficiency that could cause false negative blood test results.

Getting a definitive diagnosis for Dermatitis Herpetiformis (DH) requires more than just a physical exam. Because DH mimics other skin conditions, doctors must use a “gold standard” combination of specialized skin biopsies and blood tests to confirm that your immune system is reacting to gluten. [1][2]

The Skin Biopsy: Timing and Technique

The most critical test for DH is a Direct Immunofluorescence (DIF) skin biopsy. This is different from a standard biopsy (the kind used to check for skin cancer). [3][4]

To get an accurate result, the biopsy must be performed using these specific steps:

  • Location Matters (Perilesional Skin): The sample should be taken from perilesional skin—the normal-looking skin immediately next to a blister. [1][5] Taking a sample from the blister itself is often unhelpful because the intense inflammation there can destroy the very immune markers the doctor is looking for. [1]
  • The “Fresh Frozen” Method: The tissue sample for DIF must be processed as fresh frozen tissue. [6] Standard preservatives like formalin (used for most other biopsies) can degrade the immune deposits, leading to a false negative result. [6][7]

Reading Your Pathology Report

When you receive your pathology report, you are looking for specific, uniquely characteristic findings. [2] Ensure your report confirms the following:

Finding What it Means
Granular IgA Deposits This is the “hallmark” of DH. It means your immune system has left a “trail” of antibodies in your skin. [1][8]
Papillary Dermis This is the specific layer of skin where the IgA deposits should be found. [2][9]
“Picket Fence” Pattern A specific way the IgA deposits look under the microscope that is highly unique to DH. [10]
Neutrophilic Microabscesses Tiny clusters of white blood cells often seen in the skin layers of DH patients. [11][12]

Blood Tests (Serology)

Blood tests are used to support the biopsy findings. Your doctor will likely test for two specific antibodies:

  1. IgA anti-Tissue Transglutaminase (tTG or TG2): The standard test for Celiac Disease. [13]
  2. IgA anti-Epidermal Transglutaminase (eTG or TG3): A more specific marker for the skin-related immune response in DH. [13][14]

Note on “Negative” Blood Tests: It is possible to have DH even if your blood tests are negative. Some patients are “seronegative,” meaning their immune response is concentrated in their skin rather than their bloodstream. [15][1] If your biopsy is positive but your blood tests are negative, you still have DH. [15]

Completeness Checklist

Before your next appointment, check your records for these five items to ensure a complete diagnosis:

  • [ ] DIF Biopsy: Was it taken from normal-looking (perilesional) skin?
  • [ ] Processing: Was the sample sent “fresh” or “frozen” (not in formalin)?
  • [ ] Specific Terminology: Does the report mention “granular IgA” in the “papillary dermis”?
  • [ ] Serology: Have you had an IgA tTG or TG3 blood test?
  • [ ] Total IgA: Was your total IgA level checked? (If you are naturally deficient in IgA, standard blood tests will always be falsely negative). [16]

Frequently Asked Questions

Where should the doctor take the skin biopsy to test for Dermatitis Herpetiformis?
The biopsy should be taken from perilesional skin, which is the normal-looking skin immediately next to a blister. Taking a sample directly from the blister can destroy the immune markers needed for an accurate diagnosis.
What does 'granular IgA deposits' mean on my DH pathology report?
Granular IgA deposits are the hallmark finding of Dermatitis Herpetiformis. This means your immune system has left a specific pattern of antibodies in the layers of your skin in response to gluten.
Why does the skin biopsy sample for DH need to be fresh frozen?
The tissue sample for a Direct Immunofluorescence (DIF) biopsy must be fresh frozen because standard preservatives like formalin can destroy delicate immune deposits in the skin. Using formalin can lead to a false negative result.
Can I have Dermatitis Herpetiformis if my blood tests are negative?
Yes, some patients with Dermatitis Herpetiformis are seronegative, meaning their immune response is concentrated in their skin rather than their bloodstream. A positive skin biopsy can confirm the condition even if your blood tests are negative.
Why does my doctor need to check my total IgA levels?
If you are naturally deficient in IgA, standard celiac and DH blood tests that look for IgA antibodies will always come back falsely negative. Checking your total IgA ensures the blood tests are actually capable of detecting the condition.

Questions for Your Doctor

  • Was my skin biopsy for Direct Immunofluorescence (DIF) taken from perilesional (normal-looking) skin or directly from a blister?
  • Did the pathology report specifically identify 'granular IgA deposits' in the 'papillary dermis'?
  • Was the tissue sample for DIF processed using the 'fresh frozen' method or was it put in a formalin fixative?
  • If my blood tests for IgA antibodies were negative, did we check my 'total IgA' level to rule out an IgA deficiency?
  • Since blood tests for TG2 and TG3 can sometimes be negative in DH, do the biopsy results alone confirm my diagnosis?

Questions for You

  • Do I have a copy of my pathology report, and have I looked for the phrase 'granular IgA'?
  • Did I notice if my doctor took two separate skin samples (one for standard slides and one for the specialized DIF test)?
  • Have I been eating gluten leading up to my biopsy and blood tests (since a gluten-free diet can sometimes cause tests to be falsely negative)?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Dermatitis Herpetiformis: Novel Perspectives.

    Antiga E, Maglie R, Quintarelli L, et al.

    Frontiers in immunology 2019; (10()):1290 doi:10.3389/fimmu.2019.01290.

    PMID: 31244841
  2. 2

    [Dermatitis herpetiformis].

    Juratli HA, Görög A, Sárdy M

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 2019; (70(4)):260-264 doi:10.1007/s00105-019-4378-8.

    PMID: 30868254
  3. 3

    Diagnosis of autoimmune bullous diseases.

    van Beek N, Zillikens D, Schmidt E

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2018; (16(9)):1077-1091 doi:10.1111/ddg.13637.

    PMID: 30179336
  4. 4

    State-of-the-art diagnosis of autoimmune blistering diseases.

    van Beek N, Holtsche MM, Atefi I, et al.

    Frontiers in immunology 2024; (15()):1363032 doi:10.3389/fimmu.2024.1363032.

    PMID: 38903493
  5. 5

    An update on direct immunofluorescence for diagnosing dermatitis herpetiformis.

    Dmochowski M, Gornowicz-Porowska J, Bowszyc-Dmochowska M

    Postepy dermatologii i alergologii 2019; (36(6)):655-658 doi:10.5114/ada.2019.91415.

    PMID: 31997990
  6. 6

    The Value of Direct Immunofluorescence on Proteinase-Digested Formalin-Fixed Paraffin-Embedded Skin Biopsies.

    Valencia-Guerrero A, Deng A, Dresser K, et al.

    The American Journal of dermatopathology 2018; (40(2)):111-117 doi:10.1097/DAD.0000000000000934.

    PMID: 28816740
  7. 7

    Diagnostic Utility of Direct Immunofluorescence on Paraffin-Embedded Skin Biopsy Samples for the Diagnosis of Autoimmune Vesiculobullous Lesions.

    Bk P, Panwar H, Joshi D, et al.

    Cureus 2024; (16(3)):e56916 doi:10.7759/cureus.56916.

    PMID: 38665766
  8. 8

    Dermatitis herpetiformis.

    Salmi TT

    Clinical and experimental dermatology 2019; (44(7)):728-731 doi:10.1111/ced.13992.

    PMID: 31093998
  9. 9

    Missing Insight Into T and B Cell Responses in Dermatitis Herpetiformis.

    Kemppainen E, Salmi T, Lindfors K

    Frontiers in immunology 2021; (12()):657280 doi:10.3389/fimmu.2021.657280.

    PMID: 33854513
  10. 10

    A Comparative Study of Direct Immunofluorescence Patterns in Linear IgA Bullous Dermatosis Versus Dermatitis Herpetiformis.

    Sagut P, Lyles E, Vroman J, et al.

    The American Journal of dermatopathology 2024; (47(7)):505-511 doi:10.1097/DAD.0000000000002864.

    PMID: 39570799
  11. 11

    A Case of Dermatitis Herpetiformis With Fibrillar Immunoglobulin A Deposition: A Rare Pattern Not to Be Missed.

    Lilo MT, Yan S, Chapman MS, Linos K

    The American Journal of dermatopathology 2019; (41(7)):511-513 doi:10.1097/DAD.0000000000001380.

    PMID: 30839342
  12. 12

    Unusual site presentation of dermatitis herpetiformis: line-field confocal optical coherence tomography for effective management.

    Bettolini L, Bighetti S, Rovaris S, et al.

    Dermatology reports 2025; doi:10.4081/dr.2025.10100.

    PMID: 40963385
  13. 13

    Dermatitis Herpetiformis: An Update on Diagnosis, Disease Monitoring, and Management.

    Nguyen CN, Kim SJ

    Medicina (Kaunas, Lithuania) 2021; (57(8)) doi:10.3390/medicina57080843.

    PMID: 34441049
  14. 14

    Clinicopathological Profile of Dermatitis Herpetiformis Patients in Saudi Arabia.

    Alasmari B, Alkhodair R

    Cureus 2023; (15(10)):e48045 doi:10.7759/cureus.48045.

    PMID: 38034235
  15. 15

    Short article: Mortality and differential diagnoses of villous atrophy without coeliac antibodies.

    Schiepatti A, Biagi F, Fraternale G, et al.

    European journal of gastroenterology & hepatology 2017; (29(5)):572-576 doi:10.1097/MEG.0000000000000836.

    PMID: 28350748
  16. 16

    Modern diagnosis of celiac disease and relevant differential diagnoses in the case of cereal intolerance.

    Hahn M, Hagel AF, Hirschmann S, et al.

    Allergo journal international 2014; (23(2)):67-77 doi:10.1007/s40629-014-0006-4.

    PMID: 26120517

This page explains Dermatitis Herpetiformis (DH) diagnostic tests for educational purposes only. Always consult your dermatologist or pathologist to accurately interpret your specific biopsy and blood test results.

Stay up to date

Get notified when new research about Dermatitis herpetiformis is published.

No spam. Unsubscribe anytime.